GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GlaxoSmithKline Pharmaceuticals Limited has submitted a copy of a newspaper publication to the stock exchange, as required under listing regulations. Companies are mandated to publish key notices — such as financial results, AGM notices, or board meeting outcomes — in newspapers and then file the published copies with NSE/BSE. The filing does not announce any new corporate action, financial result, or strategic development. It is a routine regulatory compliance submission confirming that a public notice was duly published in line with SEBI requirements.
This is a standard compliance filing with no material impact on shareholders, business operations, or stock price. Investors should look to the underlying newspaper notice (e.g., quarterly results, dividend, or AGM) for any actionable information.